Last updated at 07 Apr 2025 12:13 PM
Director
DIN: 10496182
Namratha Amarnath is currently associated with 2 companies as Director. They serve as a Director at SAMITEON MEDICAL SYSTEMS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10496182.Namratha Amarnath has previously been associated with 1 company in roles such as Additional Director.Namratha Amarnath is currently involved in 1 different role. Their most recent position is with SEMANTYX TECHNOLOGIES PRIVATE LIMITED as a Director. The first company Namratha Amarnath was appointed to as a director was SAMITEON MEDICAL SYSTEMS PRIVATE LIMITED. Namratha Amarnath is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Namratha Amarnath is currently associated with 2 companies as Director. They serve as a Director at SAMITEON MEDICAL SYSTEMS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10496182.Namratha Amarnath has previously been associated with 1 company in roles such as Additional Director.Namratha Amarnath is currently involved in 1 different role. Their most recent position is with SEMANTYX TECHNOLOGIES PRIVATE LIMITED as a Director. The first company Namratha Amarnath was appointed to as a director was SAMITEON MEDICAL SYSTEMS PRIVATE LIMITED. Namratha Amarnath is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
4 Months 2 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SAMITEON MEDICAL SYSTEMS PRIVATE LIMITED | Director | 21-Oct-2024 |
| SEMANTYX TECHNOLOGIES PRIVATE LIMITED | Director | 18-Feb-2025 |